{
    "title": "Anticholinesterase",
    "questions": [
      {
        "question": "1. Which anticholinesterase agent is most commonly used in the Tensilon test for diagnosing myasthenia gravis?",
        "options": [
          "Edrophonium",
          "Neostigmine",
          "Pyridostigmine",
          "Physostigmine"
        ],
        "correct": 0
      },
      {
        "question": "2. Which anticholinesterase drug is primarily used for the chronic management of myasthenia gravis?",
        "options": [
          "Neostigmine",
          "Pyridostigmine",
          "Edrophonium",
          "Physostigmine"
        ],
        "correct": 1
      },
      {
        "question": "3. Which anticholinesterase agent is able to cross the blood-brain barrier and is therefore useful in treating central anticholinergic toxicity?",
        "options": [
          "Neostigmine",
          "Pyridostigmine",
          "Physostigmine",
          "Edrophonium"
        ],
        "correct": 2
      },
      {
        "question": "4. What is the primary mechanism of action of anticholinesterase agents?",
        "options": [
          "Inhibition of acetylcholinesterase, leading to increased acetylcholine at synapses",
          "Blocking acetylcholine receptors",
          "Enhancing release of acetylcholine from presynaptic terminals",
          "Inhibition of acetylcholine synthesis"
        ],
        "correct": 0
      },
      {
        "question": "5. Which of the following is a common adverse effect of anticholinesterase therapy?",
        "options": [
          "Bradycardia",
          "Tachycardia",
          "Dry mouth",
          "Dilated pupils"
        ],
        "correct": 0
      }
    ]
  }
  
